⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

February 12, 2024Open Access

Figure S2 from Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy

Ignacio Campillo‐Marcos Marta Casado-Peláez Verónica Dávalos Gerardo Ferrer Caterina Mata Elisabetta Mereu Gaël Roué David Valcárcel Antonieta Molero Lurdes Zamora Blanca Xicoy Laura Palomo Pamela Acha Ana Manzanares Magnus Tobiasson Eva Hellström‐Lindberg Françesc Solé Manel Esteller

View Full Paper

Ask AI

Bookmark

Share

Abstract

Distribution of mutations in CHIP-associated genes at diagnosis according to response status

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Campillo‐Marcos et al. (2024) studied this question.

synapsesocial.com/papers/68e79960b6db64358770930e https://doi.org/10.1158/2767-9764.25206452.v1

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1FIGURE 2 from Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy2024
2Figure S8 from Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy2024
3Figure S9 from Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy2024
4Table S5 from Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy2024
5Table S5 from Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy2024

More related papers

Table S7 from Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy2024
Table S7 from Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy2024
Table S8 from Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating Therapy2024